TY - JOUR
T1 - Current status in the occurrence of postoperative bleeding, perforation and residual/local recurrence during colonoscopic treatment in Japan
AU - Oka, Shiro
AU - Tanaka, Shinji
AU - Kanao, Hiroyuki
AU - Ishikawa, Hideki
AU - Watanabe, Toshiaki
AU - Igarashi, Masahiro
AU - Saito, Yutaka
AU - Ikematsu, Hiroaki
AU - Kobayashi, Kiyonori
AU - Inoue, Yuji
AU - Yahagi, Naohisa
AU - Tsuda, Sumio
AU - Simizu, Seiji
AU - Iishi, Hiroyasu
AU - Yamano, Hiroo
AU - Kudo, Shin Ei
AU - Tsuruta, Osamu
AU - Tamura, Satoshi
AU - Saito, Yusuke
AU - Cho, Eisai
AU - Fujii, Takahiro
AU - Sano, Yasushi
AU - Nakamura, Hisashi
AU - Sugihara, Kenichi
AU - Muto, Tetsuichiro
PY - 2010/10
Y1 - 2010/10
N2 - Bleeding, perforation, and residual/local recurrence are the main complications associated with colonoscopic treatment of colorectal tumor. However, current status regarding the average incidence of these complications in Japan is not available. We conducted a questionnaire survey, prepared by the Colorectal Endoscopic Resection Standardization Implementation Working Group, Japanese Society for Cancer of the Colon and Rectum (JSCCR), to clarify the incidence of postoperative bleeding, perforation, and residual/local recurrence associated with colonoscopic treatment. The total incidence of postoperative bleeding was 1.2% and the incidence was 0.26% with hot biopsy, 1.3% with polypectomy, 1.4% with endoscopic mucosal resection (EMR), and 1.7% with endoscopic submucosal dissection (ESD). The total incidence of perforation was 0.74% (0.01% with the hot biopsy, 0.17% with polypectomy, 0.91% with EMR, and 3.3% with ESD). The total incidence of residual/local recurrence was 0.73% (0.007% with hot biopsy, 0.34% with polypectomy, 1.4% with EMR, and 2.3% with ESD). Colonoscopic examination was used as a surveillance method for detecting residual/local recurrence in all hospitals. The surveillance period differed among the hospitals; however, most of the hospitals reported a surveillance period of 3-6 months with mainly transabdominal ultrasonography and computed tomography in combination with the colonoscopic examination.
AB - Bleeding, perforation, and residual/local recurrence are the main complications associated with colonoscopic treatment of colorectal tumor. However, current status regarding the average incidence of these complications in Japan is not available. We conducted a questionnaire survey, prepared by the Colorectal Endoscopic Resection Standardization Implementation Working Group, Japanese Society for Cancer of the Colon and Rectum (JSCCR), to clarify the incidence of postoperative bleeding, perforation, and residual/local recurrence associated with colonoscopic treatment. The total incidence of postoperative bleeding was 1.2% and the incidence was 0.26% with hot biopsy, 1.3% with polypectomy, 1.4% with endoscopic mucosal resection (EMR), and 1.7% with endoscopic submucosal dissection (ESD). The total incidence of perforation was 0.74% (0.01% with the hot biopsy, 0.17% with polypectomy, 0.91% with EMR, and 3.3% with ESD). The total incidence of residual/local recurrence was 0.73% (0.007% with hot biopsy, 0.34% with polypectomy, 1.4% with EMR, and 2.3% with ESD). Colonoscopic examination was used as a surveillance method for detecting residual/local recurrence in all hospitals. The surveillance period differed among the hospitals; however, most of the hospitals reported a surveillance period of 3-6 months with mainly transabdominal ultrasonography and computed tomography in combination with the colonoscopic examination.
KW - colorectal endoscopic resection
KW - perforation
KW - postoperative bleeding
KW - residual/local recurrence
UR - http://www.scopus.com/inward/record.url?scp=77957285804&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957285804&partnerID=8YFLogxK
U2 - 10.1111/j.1443-1661.2010.01016.x
DO - 10.1111/j.1443-1661.2010.01016.x
M3 - Article
C2 - 21175503
AN - SCOPUS:77957285804
SN - 0915-5635
VL - 22
SP - 376
EP - 380
JO - Digestive Endoscopy
JF - Digestive Endoscopy
IS - 4
ER -
